Publicaciones en las que colabora con Javier de Castro Carpeño (8)

2023

  1. Unravelling oligometastatic disease from the perspective of radiation and medical oncology. Part I: non-small cell lung cancer and breast cancer

    Clinical and Translational Oncology, Vol. 25, Núm. 4, pp. 882-896

  2. Unravelling oligometastatic disease from the perspective of radiation and medical oncology. Part II: prostate cancer and colorectal cancer

    Clinical and Translational Oncology, Vol. 25, Núm. 4, pp. 897-911

2022

  1. Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non-Small-Cell Lung Cancer (NADIM phase II trial)

    Journal of Clinical Oncology, Vol. 71

  2. Tumor microenvironment gene expression profiles associated to complete pathological response and disease progression in resectable NSCLC patients treated with neoadjuvant chemoimmunotherapy

    Journal for immunotherapy of cancer, Vol. 10, Núm. 9

2021

  1. Pretreatment tissue TCR repertoire evenness is associated with complete pathologic response in patients with NSCLC receiving neoadjuvant chemoimmunotherapy

    Clinical Cancer Research, Vol. 27, Núm. 21, pp. 5878-5890

  2. SEOM clinical guidelines for the treatment of malignant pleural mesothelioma (2020)

    Clinical and Translational Oncology, Vol. 23, Núm. 5, pp. 980-987

2020

  1. Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial

    The Lancet Oncology, Vol. 21, Núm. 11, pp. 1413-1422

  2. Prognostic factors for survival in patients with metastatic lung adenocarcinoma: An analysis of the SEER database

    Thoracic Cancer, Vol. 11, Núm. 11, pp. 3357-3364